Thomas Schneider

Thomas Schneider

Auto-generated profile, based on publicly available information

Thomas Schneider

Diagnostic and Interventional Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Radiology
Verified
Journal Article
Closed access
MFMatthias Alexander Fink
Matthias Alexander Fink
VMVictoria L. Mayer
Victoria L. Mayer
TSThomas Schneider
Thomas Schneider
CSConstantin Seibold
Constantin Seibold
RSRainer Stiefelhagen
Rainer Stiefelhagen
HKHans-Ulrich Kauczor
Hans-Ulrich Kauczor
Data mining of highly structured radiological reports from CT angiography enabled the development of a semiquantitative scoring system for thrombus load in pulmonary embolism. Background Many studies emphasize the role of structured reports (SRs) because they are readily accessible for further automated analyses. However, using SR data obtained in clinical routine for re...

1 December 2024 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Open access
DLDominik Leitz
Dominik Leitz
PKPhilip Konietzke
Philip Konietzke
WWWilli L. Wagner
Willi L. Wagner
MMMara Mertiny
Mara Mertiny
CBClaudia Benke
Claudia Benke
MWMark O. Wielpuetz
Mark O. Wielpuetz
IPF diagnosis, particularly in early stages, remains challenging. In this study, micro-CT is used in conditional Nedd4-2−/− mice to closely monitor the onset and progression of progressive pulmonary fibrosis in vivo. Together with high-resolution post mortem micro-CT, this allowed us to track how nonspecific lung lesions develop into key IPF-like features. This approach offers a noninvasive method to monitor pulmonary fibrosis, providing a quantitative endpoint for the preclinical evaluation of novel antifibrotic strategies.

25 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PSPatrick Stein
Patrick Stein
FWFelix Wuennemann
Felix Wuennemann
TSThomas Schneider
Thomas Schneider
FZFelix Zeifang
Felix Zeifang
IBIris Burkholder
Iris Burkholder
CRChristoph Rehnitz
Christoph Rehnitz
This study investigated the ability of T2 mapping to assess the glenoid labrum and to differentiate between healthy labral substances and superior labral anterior posterior (SLAP) lesions using arthroscopy as the gold standard. Eighteen patients (mean age: 52.4 ± 14.72 years, 12 men) with shoulder pain were examined using 3-Tesla T2 mapping. All the patients underwent shoulder arthroscopy. Using morphological sequences for correlation, regions of interest covering the entire labral substance were placed in the corresponding T2 maps. The diagnostic cutoff values, sensitivities, and specificities, as well as the inter-reader correlation coefficients (ICCs) determined by two independent radiologists, were calculated. The mean T2 value was 20.8 ± 2.4 ms for the healthy labral substances and 37.7 ± 10.63 ms in the patients with SLAP lesions. The maximum T2 value in normal labrum (21.2 ms) was lower than the minimum T2 value in the patients with SLAP lesions (27.8 ms), leading to sensitivities, specificities, and positive and negative predictive values of 100% (95% CI 54.1–100.0) for all the cutoff values between 21.2 and 27.8 ms. The ICCs ranged from 0.91 to 0.99. In summary, the data suggest that evaluation and quantification of the labral (ultra)structural integrity using T2 mapping may allow discrimination between arthroscopically confirmed SLAP lesions and a healthy glenoid labrum. T2 mapping may therefore be helpful in diagnosing patients with suspected labral damage.

23 August 2023 in Tomography
Verified
Journal Article
Open access
PDF file
PSPatrick Stein
Patrick Stein
FWFelix Wuennemann
Felix Wuennemann
TSThomas Schneider
Thomas Schneider
FZFelix Zeifang
Felix Zeifang
IBIris Burkholder
Iris Burkholder
CRChristoph Rehnitz
Christoph Rehnitz
This study evaluates how far T2 mapping can identify arthroscopically confirmed pathologies in the long biceps tendon (LBT) and quantify the T2 values in healthy and pathological tendon substance. This study comprised eighteen patients experiencing serious shoulder discomfort, all of whom underwent magnetic resonance imaging, including T2 mapping sequences, followed by shoulder joint arthroscopy. Regions of interest were meticulously positioned on their respective T2 maps, capturing the sulcal portion of the LBT and allowing for the quantification of the average T2 values. Subsequent analyses included the calculation of diagnostic cut-off values, sensitivities, and specificities for the detection of tendon pathologies, and the calculation of inter-reader correlation coefficients (ICCs) involving two independent radiologists. The average T2 value for healthy subjects was measured at 23.3 ± 4.6 ms, while patients with tendinopathy displayed a markedly higher value, at 47.9 ± 7.8 ms. Of note, the maximum T2 value identified in healthy tendons (29.6 ms) proved to be lower than the minimal value measured in pathological tendons (33.8 ms), resulting in a sensitivity and specificity of 100% (95% confidence interval 63.1–100) across all cut-off values ranging from 29.6 to 33.8 ms. The ICCs were found to range from 0.93 to 0.99. In conclusion, T2 mapping is able to assess and quantify healthy LBTs and can distinguish them from tendon pathology. T2 mapping may provide information on the (ultra-)structural integrity of tendinous tissue, facilitating early diagnosis, prompt therapeutic intervention, and quantitative monitoring after conservative or surgical treatments of LBT.